Test Price
2,800 AED✅ Home Collection Available
BBS7 Gene Bardet-Biedl Syndrome Type 7 Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
EXECUTIVE SUMMARY
Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO-accredited next-generation sequencing (NGS).
Premium Logistics: VIP mobile phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM.
Clinical Guidance: Post-test telephonic interpretation and genetic counseling by Consultant Medical Genetics Lina Osama Zaki Quteineh (DHA ID: 9294403).
Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Corporate Oversight: DNA Labs UAE operates under DHA Facility License Number 1143. All genetic tests are conducted in our CAP-accredited, ISO 9001:2015 certified laboratory located in Dubai Healthcare City.
Test Overview & Methodology
The BBS7 Gene Test utilizes Next-Generation Sequencing (NGS) on the Illumina platform to detect single nucleotide variants (SNVs), insertions, deletions, and copy number variations (CNVs) in the BBS7 gene. This comprehensive analysis provides definitive confirmation or exclusion of Bardet-Biedl Syndrome Type 7, a rare autosomal recessive ciliopathy affecting renal function, vision, endocrine health, and limb development. Early molecular diagnosis is critical for initiating life-saving renal surveillance, weight management protocols, and visual rehabilitation strategies.
| Feature | Our Test (NGS – UAE) | Closest Alternative |
|---|---|---|
| Methodology | Full BBS7 gene sequencing + CNV analysis on Illumina platform | Sanger sequencing of selected exons – limited variant detection |
| Diagnostic Sensitivity | >99.9% for SNVs & indels | ~95% (misses deep intronic or structural variants) |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Genetic Counseling | Mandatory pre‑ & post‑test session included | Often not provided |
| Home Collection | Cold‑chain ISO‑certified (8 AM‑11 PM) | Clinic visit only |
Physician Insight & Safety Protocols
“The BBS7 test is a powerful diagnostic tool, yet it demands clinical correlation. A positive result marks the beginning of a lifelong multidisciplinary journey; a negative result does not exclude all ciliopathies. Always interpret alongside renal ultrasound, ophthalmologic exam, and endocrinologic assessment.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory & Clinical Precautions
⚠️ Critical Advisory: Do not discontinue prescribed medication or alter treatment without explicit consultation with your managing physician. This genetic report is not a standalone therapeutic directive and must be integrated into a comprehensive clinical assessment by a qualified specialist.
Exclusion Criteria & Safety Red Flags
- Exclusion Criteria: This test is not for patients in acute renal failure, retinal detachment, or severe electrolyte imbalance. Stabilize emergency conditions first.
- Incidental Findings: NGS may reveal secondary genetic risks; a DHA‑licensed genetic counselor will explain implications and obtain informed consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Emergency Red Flags: Sudden visual loss, anuria, severe abdominal distension, or encephalopathy demand immediate hospital attendance.
- Data Confidentiality: Genomic data is stored under UAE PDPL (Federal Decree-Law No. 45 of 2021), encrypted and never shared without explicit consent.
Patient FAQ & Clinical Guidance
1. What conditions does the BBS7 gene test detect?
The test identifies pathogenic mutations in the BBS7 gene, confirming Bardet-Biedl Syndrome Type 7—a ciliopathy causing retinal dystrophy, truncal obesity, polydactyly, renal anomalies, and hypogonadism. A definitive molecular diagnosis enables early intervention and cascade family screening.
2. How should I prepare for the blood collection?
No fasting or special preparation is required. A trained nurse collects the sample via our ISO‑certified cold‑chain home service from 8 AM‑11 PM. A pre‑genetic counselling session is obligatory to document the pedigree and discuss possible outcomes.
3. When will I receive results, and what support follows?
Results are delivered in 3–4 weeks with a mandatory telephonic interpretation session by the clinical genetics team. We explain the report, its implications for management, and arrange referrals to pediatric nephrology, endocrinology, and ophthalmology as needed.
UAE Regulatory & Data Privacy Adherence
This molecular diagnostic service fully complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is processed, stored, and transmitted under strict encryption protocols within the UAE jurisdiction. Patient consent is obtained and managed per the highest standards of medical data governance and clinical safety.
Clinical & Logistical Metadata
| Test Name | BBS7 Gene Bardet-Biedl Syndrome Type 7 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (Peripheral) |
| Methodology Used | Next-Generation Sequencing (NGS) + CNV Analysis |
| ICD-10-CM Code | Q87.8 |
| LOINC Code | 82319-9 |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians